ArticleBMC geriatrics2025
Associations of high protein supplements with gut microbiota and skeletal muscle mass in hospitalized older people.
Article in BMC geriatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
BACKGROUND/
objectiveProlonged bed rest is highly prevalent among hospitalized older adults and markedly accelerates the loss of muscle mass and physical function. Currently, there are no effective interventions to counteract this decline, and the underlying mechanisms remain poorly characterized. This study aimed to investigate whether high protein intake can simultaneously modulate muscle mass and the gut microbiota, and whether gut microbial composition mediates muscle regulation in hospitalized older people.
methodsA self-controlled study was conducted on 43 older patients aged 60 to 90 years old with low skeletal muscle mass. During the 3-month intervention phase, all participants received approximately 36 g of high-protein supplementation daily, comprising both casein and whey proteins. This was followed by a 3-month control phase in which participants received standard nursing care without protein supplementation.
resultsA significant increase in skeletal muscle mass index from baseline was seen in male group at 3 months (6.0–6.3 kg/m2) but declined to 6.1 kg/m2 at 6 months (P < 0.05). No significant changes were observed in females (P > 0.05). Gut microbiota analysis revealed that bacterial diversity and microbial structure were affected by protein supplementation and differed by sex. Males exhibited a greater abundance of SMI- and SMM-associated beneficial bacteria following protein intake. Furthermore, metabolic pathway analysis indicated that microbial functions related to amino acid synthesis were positively correlated with SMI-linked species such as Blautia wexlerae and Corynebacterium dentalis.
conclusionsHigh-protein supplementation may promote muscle anabolism in hospitalized older males by modulating the composition and metabolic function of the gut microbiota, specifically by enhancing microbial pathways related to amino acid synthesis. These results suggest the presence of a gut-muscle axis and highlight the potential of targeted protein interventions to counteract inactivity-related muscle loss in older patients.
trial registrationThe trial was registered at Chinese Clinical Trial Registry with identifier ChiCTR2400085432 on 07/06/2024.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.